Home » Topics » BioWorld Science

BioWorld Science
RSS

Bellerophon reports initial data from acute hemodynamic study of INOpulse

Nov. 13, 2019

New exploratory phase I/II study in Japan assesses NS-089 in Duchenne muscular dystrophy

Nov. 13, 2019

Break out the sparkling apple cider for DUR-928 alcoholic hepatitis data

Nov. 13, 2019

New P2X7 receptor antagonists identified at Shionogi

Nov. 13, 2019

Vertex, Merck & Co. describe endoplasmic reticulum stress inducers

Nov. 13, 2019

Macrocyclic oligopeptides identified at Roche

Nov. 13, 2019

Celgene patents compounds for diffuse large B-cell lymphoma

Nov. 13, 2019

Virginia Tech Intellectual Properties describes mitochondrial uncouplers

Nov. 13, 2019

Positive data presented from initial cohort of phase IIb study of ORMD-0801 in T2D

Nov. 13, 2019

KD-025 meets primary endpoint at interim analysis of pivotal ROCKstar study in chronic GvHD

Nov. 13, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...